WallStreetZenWallStreetZen

NASDAQ: SRPT
Sarepta Therapeutics Inc Stock Ownership - Who owns Sarepta Therapeutics?

Insider buying vs selling

Have Sarepta Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Kathryn Jean BoorDirector2024-03-11761$122.93
$93.55kSell
Hans Lennart Rudolf WigzellDirector2024-03-0815,000$13.90
$208.50kBuy
Louise RodinoklapacHead of RD CSO2024-03-08909$123.14
$111.93kSell
Ryan Edward BrownEVP General Counsel2024-03-08899$123.14
$110.70kSell
Hans Lennart Rudolf WigzellDirector2024-03-08100$122.39
$12.24kSell
Hans Lennart Rudolf WigzellDirector2024-03-0811,745$123.10
$1.45MSell
Hans Lennart Rudolf WigzellDirector2024-03-083,155$123.85
$390.75kSell
Bilal ArifChief Tech Ops Officer2024-03-08472$123.14
$58.12kSell
Ian Michael EstepanChief Financial Officer2024-03-081,035$123.14
$127.45kSell
Ian Michael EstepanChief Financial Officer2024-03-07526$120.49
$63.38kSell

1 of 5

SRPT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SRPT insiders and whales buy or sell their stock.

SRPT Shareholders

What type of owners hold Sarepta Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Black Bear Offshore Master Fund LP10.56%9,914,211$1.27BInsider
Vanguard Group Inc9.39%8,816,124$1.13BInstitution
Blackrock Inc6.62%6,211,792$796.66MInstitution
Eastbourne Capital Management LLC6.03%5,659,211$725.79MInsider
Janus Henderson Group PLC5.70%5,345,785$685.60MInstitution
Capital International Investors5.05%4,741,485$608.10MInstitution
Avoro Capital Advisors LLC4.63%4,344,444$557.17MInstitution
Wellington Management Group LLP4.40%4,127,610$529.37MInstitution
Richard Barry3.39%3,181,688$408.05MInsider
Rockall Emerging Markets Master Fund Ltd3.13%2,935,696$376.50MInsider

1 of 3

SRPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SRPT73.88%26.12%Net BuyingNet Selling
INCY79.30%20.70%Net SellingNet Buying
UTHR87.59%12.41%Net SellingNet Selling
TECH97.66%2.34%Net BuyingNet Selling
LEGN23.61%0.00%

Sarepta Therapeutics Stock Ownership FAQ

Who owns Sarepta Therapeutics?

Sarepta Therapeutics (NASDAQ: SRPT) is owned by 86.59% institutional shareholders, 30.62% Sarepta Therapeutics insiders, and 0.00% retail investors. Black Bear Offshore Master Fund LP is the largest individual Sarepta Therapeutics shareholder, owning 9.91M shares representing 10.56% of the company. Black Bear Offshore Master Fund LP's Sarepta Therapeutics shares are currently valued at $1.29B.

If you're new to stock investing, here's how to buy Sarepta Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.